KNOW Communication Intervention for Alzheimer's Disease
Trial Summary
What is the purpose of this trial?
The proposed research is consistent with broader public health goals focused on improving communication regarding end-of-life care and the Centers for Medicare and Medicaid Services' (CMS) call for increased patient engagement in advance care planning (ACP) as part of standard care. The proposed study will address this public health issue by developing a communication-based intervention designed to improve Alzheimer's Disease and Related Dementias (ADRD) patients' and care partners' engagement in ACP, distress and care partner burden, and completion of advance directives and receipt of goal-concordant care at the end-of-life. Therefore, this study is aligned with the National Institute on Aging's long-term goal to improve the quality of care for ADRD patients and CMS's goal to increase engagement in ACP.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment KNOW for Alzheimer's disease?
The research suggests that structured communication interventions, like the KNOW treatment, can improve communication in Alzheimer's patients. Studies show that caregiver training programs and structured conversations can enhance communication relevance and reduce misunderstandings, which are key components of the KNOW treatment.12345
How does the KNOW Communication Intervention treatment for Alzheimer's disease differ from other treatments?
The KNOW Communication Intervention is unique because it focuses on improving communication between Alzheimer's patients and their caregivers through specific strategies, rather than using medication. This approach aims to reduce stress and improve interactions by training caregivers in effective communication techniques.13678
Research Team
Sara Czaja, PhD
Principal Investigator
Weill Medical College of Cornell University
Eligibility Criteria
This trial is for people aged 65 or older with mild to moderate memory impairment due to conditions like Dementia or Alzheimer's. They must have a certain level of cognitive function, be able to appoint someone for healthcare decisions, and have an informal caregiver. It's not for those under 18, non-English speakers, severely ill individuals, those with major psychiatric disorders, active cancer treatment patients, or those who've already completed advance directives.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention Development
Development of the communication-based intervention called KNow the Optimal Way (KNOW) for Alzheimer's Disease and Related Dementias (ADRD) patients and care partners
Intervention Evaluation
Evaluation of the feasibility and acceptability of the intervention, and testing its preliminary efficacy on various outcomes
Follow-up
Participants are monitored for changes in engagement in advance care planning, psychological distress, and communication quality
Treatment Details
Interventions
- KNOW
Find a Clinic Near You
Who Is Running the Clinical Trial?
Weill Medical College of Cornell University
Lead Sponsor
National Institute on Aging (NIA)
Collaborator